S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
S&P 500   4,662.85
DOW   35,911.81
QQQ   380.01
NASDAQ:RNXT

RenovoRx News Headlines

$4.06
-0.06 (-1.46%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.93
$4.14
50-Day Range
$4.01
$8.50
52-Week Range
$3.81
$16.74
Volume
47,111 shs
Average Volume
203,971 shs
Market Capitalization
$36.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Get RenovoRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

RenovoRx Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RNXT
News Sentiment

0.00

0.31

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RNXT Articles
This Week

1

1

RNXT Articles
Average Week



RenovoRx (NASDAQ:RNXT) News Headlines Today

SourceHeadline
MarketBeat logo-$0.18 EPS Expected for RenovoRx Inc (NASDAQ:RNXT) This Quarter
americanbankingnews.com - January 13 at 10:28 AM
finance.yahoo.com logoRenovoRx to Present at the H.C. Wainwright Bioconnect Virtual Conference
finance.yahoo.com - January 6 at 8:29 AM
finance.yahoo.com logoWe're Not Very Worried About RenovoRx's (NASDAQ:RNXT) Cash Burn Rate
finance.yahoo.com - November 26 at 8:10 AM
finance.yahoo.com logoRenovoRx Announces Third Quarter 2021 Financial Results
finance.yahoo.com - November 15 at 5:21 PM
finance.yahoo.com logoRenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual Meeting
finance.yahoo.com - November 11 at 8:52 AM
finance.yahoo.com logoPresentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic Cancer
finance.yahoo.com - November 9 at 9:16 AM
finance.yahoo.com logoRenovoRx, Inc. (RNXT)
finance.yahoo.com - September 27 at 12:52 PM
nasdaq.com logoTop Health Care Stocks To Buy In September 2021? 4 To Watch
nasdaq.com - September 7 at 4:49 PM
markets.businessinsider.com logoRenovoRx Gets New 510(k) Clearance For RenovoCath Delivery System; Stock Up
markets.businessinsider.com - September 7 at 7:05 AM
nasdaq.com logoRenovoRx, Inc. Common Stock (RNXT)
nasdaq.com - August 31 at 6:18 PM
benzinga.com logoWhy RenovoRx Stock Is Trading Higher Today
benzinga.com - August 30 at 9:48 PM
Get RenovoRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.